(The author is a Reuters Breakingviews columnist. The opinions
expressed are their own. Refiles to fix formatting.)
HONG KONG, March 1 (Reuters Breakingviews) - Concise
insights on global finance in the Covid-19 era.
-------------------------------------------------
PROFIT CHARMING. Technology-focused China Renaissance 1911.HK
is doing better than some of its clients’ share prices. The Hong
Kong-listed investment bank said https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0301/2021030100033.pdf
on Monday it expects a 311% rise in net profit for 2020. Gains
come from its investment management unit and its advisory work,
which included fintech lender Lufax’s LU.N $2.4 billion New
York initial public offering and the $3.5 billion Hong Kong
debut of JD Health 6618.HK .
Shares jumped over 9% on the news, leaving China Renaissance
just shy of last month’s all-time peak. That only adds to its
relative priciness http://www.breakingviews.com/considered-view/boutique-bank-rides-chinese-unicorns-downhill/?bved=NDE%3D&bvshr=MTYwMzc1:
the stock trades at 1.9 times estimates of its book value for
2021, versus 1 times for the Hong Kong shares of rival China
International Capital Corporation 3908.HK and 1.4 times
international giant Morgan Stanley MS.N .
Bankers are off to a good start in 2021 with listings galore
planned but both those and the chances of China Renaissance
repeating its gains depend on stocks remaining all charged
up.(by Jennifer Hughes)
On Twitter http://twitter.com/breakingviews
Earlier in Capital Calls:
Beyond Meat’s murky future urn:newsml:reuters.com:*:nL1N2KW2LE
DoorDash is overstuffed urn:newsml:reuters.com:*:nL1N2KW28B
CEOs are not vaccine VIPs urn:newsml:reuters.com:*:nL1N2KW21G
Barclays’ legal win is moral loss urn:newsml:reuters.com:*:nL4N2KW4UY
Saint Gobain fails board refurb urn:newsml:reuters.com:*:nL4N2KW3TF
- SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS http://bit.ly/BVsubscribe